Tirzepatide Works Just as Well and as Safely for Adults Over 65
This analysis suggests tirzepatide may be a reasonable weight option for older adults after weighing risks.
Tirzepatide is the popular GLP-1 weight loss drug also sold as Mounjaro and Zepbound. This look back at big trials found it helped adults over 65 lose weight and improve heart and blood sugar health. The benefits and side effects matched what younger adults saw, with no new risks for older bodies.
Conflict of Interest Disclosure: Tirzepatide is made by Eli Lilly, which runs the SURMOUNT and SUMMIT trials.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchMetformin Added Nothing to Diet and Exercise for Older Adults' Strength
Metformin has a big fan club in longevity circles, but this trial puts a dent in the hype.
A 9-Year Mailed Exercise Program Barely Moved the Needle in Older Women
Nearly 50,000 women aged 66 to 99 were randomly assigned to a long-running, remotely delivered program that encouraged more movement and…
Why Small Nutrient Gaps May Quietly Speed Up Aging After Your 40s
This review argues that common shortfalls in vitamins and minerals like B vitamins, C, D, E, zinc, and selenium may speed up biological…